{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04396379",
            "orgStudyIdInfo": {
                "id": "TPL0002"
            },
            "organization": {
                "fullName": "Mitre Medical Corp.",
                "class": "INDUSTRY"
            },
            "briefTitle": "Epicardial Mitral Touch System for Mitral Insufficiency",
            "officialTitle": "ENRAPTUS Epicardial Mitral Touch System for Mitral Insufficiency",
            "acronym": "ENRAPTUS",
            "therapeuticArea": [
                "Other"
            ],
            "study": "epicardial-mitral-touch-system-for-mitral-insufficiency"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-01",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-09-10",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2020-05-15",
            "studyFirstSubmitQcDate": "2020-05-15",
            "studyFirstPostDateStruct": {
                "date": "2020-05-20",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-01-02",
            "lastUpdatePostDateStruct": {
                "date": "2023-01-04",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Mitre Medical Corp.",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "BSWRI Cardiac Imaging Core Lab (CICL)",
                    "class": "UNKNOWN"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true,
            "isUnapprovedDevice": true
        },
        "descriptionModule": {
            "briefSummary": "To evaluate the safety and performance of the Mitral Touch System to treat mitral insufficiency in patients who are to undergo cardiac surgery with either a sternotomy or thoracotomy who present with moderate to severe ischemic or functional mitral regurgitation.",
            "detailedDescription": "The Mitral Touch Systems is intended to epicardially reshape the mitral valve annulus and left ventricle without the need for cardiopulmonary bypass (CPB) and open-heart access (atriotomy), in patients with left ventricular dilation and mitral valve insufficiency in patients with ischemic or functional MR."
        },
        "conditionsModule": {
            "conditions": [
                "Ischemic Mitral Regurgitation",
                "Functional Mitral Regurgitation"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "interventionModelDescription": "prospective, single arm, un-blinded, multi-center early feasibility study",
                "primaryPurpose": "DEVICE_FEASIBILITY",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 10,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Device Implantation",
                    "type": "EXPERIMENTAL",
                    "description": "To epicardially reshape the mitral valve annulus and left ventricle without the need for cardiopulmonary bypass (CPB) and open-heart access (atriotomy) using an epicardial implant.",
                    "interventionNames": [
                        "Device: Implant an epicardial device to reshape the mitral valve annulus"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "Implant an epicardial device to reshape the mitral valve annulus",
                    "description": "The implant is intended to epicardially reshape the mitral valve annulus and left ventricle without the need for cardiopulmonary bypass (CPB) and open-heart access (atriotomy), in patients with left ventricular dilation and mitral valve insufficiency in patients with ischemic or functional MR.",
                    "armGroupLabels": [
                        "Device Implantation"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Rate of Freedom from Major Adverse Events",
                    "description": "Freedom from Major Adverse Events such as death, stroke, Increase of NYHA \\>1, Re-Hospitalization or reoperation of the Mitral Valve",
                    "timeFrame": "Procedure through 30 days"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Rate of Technical Feasibility to implant the Mitral Touch Device",
                    "description": "Septal lateral diameter reduction of the mitral valve at implantation, Reduction in MR Grade by at least 1 grade from baseline",
                    "timeFrame": "Procedure"
                },
                {
                    "measure": "Rate of Freedom from Serious Adverse Events from Implantation of the Mitral Touch Device",
                    "description": "Implantation of the Mitral Touch Device without Serious Adverse Events",
                    "timeFrame": "procedure"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Moderate or greater (2+) ischemic\n* Functional Mitral regurgitation by 2D echocardiography using an integrative method\n* Patient is scheduled for cardiac surgery (e.g. CABG including patients on the waiting list for Heart Transplantation)\n* Patient is 22 years of age or older\n* Patient is willing and able to sign Informed Consent Form\n* Within 90 days patients should be on stable optimally uptitrated medical therapy recommended according to current guidelines23 as standard of care for heart failure therapy in the United States\n\nExclusion Criteria:\n\n* Any evidence of structural (chordal or leaflet) mitral valve disease\n* Inability to derive ERO, LVESVI or LVEDVI by TTE\n* Prior surgical or percutaneous mitral valve intervention\n* Contraindication to cardiopulmonary bypass (CPB)\n* Clinical signs of cardiogenic shock\n* Treatment with chronic intravenous inotropic therapy\n* Severe, irreversible pulmonary hypertension in the judgement of the investigator\n* ST segment elevation requiring intervention within 7 days prior to randomization\n* Congenital heart disease (except PFO or ASD)\n* Evidence of cirrhosis or hepatic synthetic failure\n* Renal insufficiency (eGFR \\< 30 ml/min)\n* History of endocarditis or current endocarditis\n* Ejection fraction \\<25%\n* NY heart class IV\n* MV diameters \\> 7cm\n* Any coronary artery calcification at site of placement as determined by angiogram\n* Myxomatous mitral regurgitation\n* Women who are pregnant (by history of menstrual period or pregnancy test if history is considered unreliable)\n* Abnormal cardiac anatomy discovered prior to surgery or during procedure\n* Pericardial adhesions\n* Insufficient clinical signature reduction of mitral regurgitation during device sizing and placement. (No device remains, patient moved to only 30-Day follow-up.)",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "22 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "John MacMahon",
                    "role": "CONTACT",
                    "phone": "(408)-940-5587",
                    "email": "jmacmahon@mitremedical.com"
                },
                {
                    "name": "Laura A Minarsch",
                    "role": "CONTACT",
                    "phone": "(949)2805700",
                    "email": "laura22@mmc-medical.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Robert L Smith II, MD",
                    "affiliation": "Baylor Scott and White Medical Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Baylor Scott and White",
                    "city": "Plano",
                    "state": "Texas",
                    "zip": "75093",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Robert L. Smith, MD",
                            "role": "CONTACT",
                            "phone": "469-814-3278",
                            "email": "robert.smith1@bswhealth.org"
                        },
                        {
                            "name": "Robert L. Smith, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.01984,
                        "lon": -96.69889
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008944",
                    "term": "Mitral Valve Insufficiency"
                }
            ],
            "ancestors": [
                {
                    "id": "D000006349",
                    "term": "Heart Valve Diseases"
                },
                {
                    "id": "D000006331",
                    "term": "Heart Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10543",
                    "name": "Ischemia",
                    "relevance": "LOW"
                },
                {
                    "id": "M11910",
                    "name": "Mitral Valve Insufficiency",
                    "asFound": "Mitral Regurgitation",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9437",
                    "name": "Heart Valve Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M9419",
                    "name": "Heart Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                }
            ]
        }
    },
    "hasResults": false
}